{"id":"insulin-therapy","safety":{"commonSideEffects":[{"rate":"variable, dose-dependent","effect":"Hypoglycemia"},{"rate":"common","effect":"Weight gain"},{"rate":"5-10","effect":"Injection site reactions"},{"rate":"rare to uncommon","effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin is a peptide hormone that binds to insulin receptors on cell surfaces, facilitating glucose transport into muscle, fat, and liver cells. This lowers blood glucose levels and enables cells to utilize glucose for energy or store it as glycogen. Insulin therapy is used when the pancreas cannot produce sufficient insulin endogenously, as in type 1 diabetes or advanced type 2 diabetes.","oneSentence":"Insulin therapy replaces or supplements the body's own insulin to regulate blood glucose by promoting glucose uptake into cells and storage as glycogen.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:22.079Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"},{"name":"Gestational diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT05713799","phase":"PHASE2","title":"Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Insulin Resistance, Obesity","enrollment":60},{"nctId":"NCT07494474","phase":"","title":"Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-08-31","conditions":"Autoimmune Thyroid Disease","enrollment":834},{"nctId":"NCT02346838","phase":"NA","title":"Prebiotics, Gut Microbiota, and Cardiometabolic Health","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2014-01","conditions":"Prediabetes","enrollment":22},{"nctId":"NCT07293715","phase":"PHASE4","title":"Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2026-02-25","conditions":"Pregnancy, High Risk, Type 1 Diabetes","enrollment":44},{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT07037420","phase":"PHASE2","title":"ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly","status":"RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2025-10-28","conditions":"Acromegaly","enrollment":60},{"nctId":"NCT07495956","phase":"PHASE1, PHASE2","title":"cfMSC Therapy for Diabetes","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2026-03-16","conditions":"Type II Diabetes Mellitus","enrollment":30},{"nctId":"NCT07361874","phase":"NA","title":"IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-05","conditions":"Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's","enrollment":75},{"nctId":"NCT05062785","phase":"PHASE1","title":"Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants","status":"COMPLETED","sponsor":"Robert Silbergleit","startDate":"2021-10-04","conditions":"Out-Of-Hospital Cardiac Arrest, Healthy","enrollment":24},{"nctId":"NCT07491133","phase":"NA","title":"Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2026-03","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT04128995","phase":"PHASE4","title":"Surgical or Medical Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-12-15","conditions":"Diabetes Mellitus, Type 2, Pediatric Obesity, Bariatric Surgery Candidate","enrollment":88},{"nctId":"NCT03527537","phase":"PHASE4","title":"Gestational Diabetes and Pharmacotherapy (GAP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2021-05-04","conditions":"Gestational Diabetes","enrollment":416},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT07278063","phase":"NA","title":"Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2026-05","conditions":"Type 1 Diabetes Mellitus, Glycemic Variability, Sex Characteristics","enrollment":50},{"nctId":"NCT07460336","phase":"NA","title":"Effects of Cofrogliptin on Beta-Cell Function in LADA Patients","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-03-15","conditions":"Latent Autoimmune Diabetes in Adults (LADA)","enrollment":84},{"nctId":"NCT06503809","phase":"NA","title":"Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-08-12","conditions":"Diabetes Mellitus, Type 1","enrollment":58},{"nctId":"NCT05663515","phase":"","title":"A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":"Pancreatic Cancer","enrollment":24000},{"nctId":"NCT07480993","phase":"","title":"Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-01-15","conditions":"Polycystic Ovary Syndrome (PCOS), Betatrophin, Body Mass Index (BMI)","enrollment":90},{"nctId":"NCT04645693","phase":"","title":"The Impact of Oral Health in HIV Patients on Antiretroviral Therapy","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-02-24","conditions":"HIV, Periodontal Diseases, Caries","enrollment":227},{"nctId":"NCT07479134","phase":"NA","title":"Production of Stem Cells for the Generation of Pancreatic Cells","status":"RECRUITING","sponsor":"Ospedale San Raffaele","startDate":"2026-03-01","conditions":"Diabetes","enrollment":100},{"nctId":"NCT07471854","phase":"NA","title":"Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05-01","conditions":"Acne Scars - Atrophic","enrollment":42},{"nctId":"NCT07423637","phase":"NA","title":"The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-04-01","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT07120828","phase":"PHASE4","title":"The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity","status":"COMPLETED","sponsor":"Erbil Polytechnic University","startDate":"2025-07-15","conditions":"Type 2 Diabetes, Obese Diabetics, Obese Patients (BMI ≥ 30 kg/m²)","enrollment":260},{"nctId":"NCT06198725","phase":"NA","title":"Intervention for Children With Type 1 Diabetes Targeting Gut Microbes","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2024-01-08","conditions":"Type 1 Diabetes","enrollment":110},{"nctId":"NCT07472920","phase":"NA","title":"Empagliflozin Adjunctive Therapy in Bipolar Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2026-03-09","conditions":"Bipolar Disorder, Bipolar Depression, Insulin Resistance","enrollment":20},{"nctId":"NCT07212179","phase":"NA","title":"Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery","status":"RECRUITING","sponsor":"Anas El Fathi","startDate":"2026-03-03","conditions":"Type 1 Diabetes","enrollment":6},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT06762314","phase":"PHASE2","title":"Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2025-01-20","conditions":"Diabetes","enrollment":105},{"nctId":"NCT03878706","phase":"","title":"The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination","status":"RECRUITING","sponsor":"University of Athens","startDate":"2017-11-03","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT06579404","phase":"NA","title":"Closed-loop in Adults With Type 2 Diabetes","status":"RECRUITING","sponsor":"University of Cambridge","startDate":"2024-12-06","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":224},{"nctId":"NCT07329088","phase":"NA","title":"Isoleucine Addition Treatment Effects in a Controlled Diet Study","status":"NOT_YET_RECRUITING","sponsor":"Jean L. Fry","startDate":"2026-05-04","conditions":"Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Metabolic Syndrome (MetS), Obesity & Overweight","enrollment":40},{"nctId":"NCT07467967","phase":"NA","title":"Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"University Tunis El Manar","startDate":"2026-07-15","conditions":"Diabete Type 2","enrollment":130},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT07137585","phase":"PHASE1","title":"A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-09-30","conditions":"Type 2 Diabetes Mellitus, Obesity, Overweight","enrollment":30},{"nctId":"NCT06334133","phase":"PHASE3","title":"Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes","status":"RECRUITING","sponsor":"vTv Therapeutics","startDate":"2024-06-14","conditions":"Diabetes Mellitus, Type 1","enrollment":150},{"nctId":"NCT04149262","phase":"","title":"Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-11-15","conditions":"Type 1 Diabetes","enrollment":44},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT06148376","phase":"","title":"Application of a Protocol of Personalized Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Doses of Insulin in Routine Clinical Care","status":"COMPLETED","sponsor":"Hospital Arnau de Vilanova","startDate":"2023-12-01","conditions":"Type 2 Diabetes Mellitus, Multiple Dose Insulin Therapy","enrollment":239},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT02088658","phase":"NA","title":"Technology Intensified Diabetes Education Study in African Americans","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2013-05","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent","enrollment":200},{"nctId":"NCT07455643","phase":"NA","title":"Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts","status":"COMPLETED","sponsor":"University of Catania","startDate":"2025-04-20","conditions":"Type 1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT07452913","phase":"PHASE4","title":"Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Bahria University","startDate":"2026-01-01","conditions":"Type 2 Diabetes Mellitus","enrollment":110},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":"Dry Eye, Insulin","enrollment":116},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT05539872","phase":"PHASE2, PHASE3","title":"Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2022-08-22","conditions":"Pharmacokinetics, Pharmacodynamics","enrollment":69},{"nctId":"NCT06747468","phase":"PHASE3","title":"Avexitide for Treatment of Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amylyx Pharmaceuticals Inc.","startDate":"2025-04-29","conditions":"Post Bariatric Hypoglycemia","enrollment":75},{"nctId":"NCT07364045","phase":"NA","title":"Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2026-01-30","conditions":"Type 2 Diabetes","enrollment":104},{"nctId":"NCT06640478","phase":"NA","title":"A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2024-11-20","conditions":"Type 1 Diabetes","enrollment":20},{"nctId":"NCT07158047","phase":"NA","title":"Repeated Far Infrared Sauna Bathing in Adults With Obesity","status":"RECRUITING","sponsor":"University of Oregon","startDate":"2022-03-07","conditions":"Obesity (Disorder)","enrollment":20},{"nctId":"NCT03868592","phase":"NA","title":"Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-08-01","conditions":"Obesity, Morbid","enrollment":30},{"nctId":"NCT02653092","phase":"NA","title":"Reprometabolic Syndrome Mediates Subfertility in Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2016-06","conditions":"Obesity, Infertility, Hypogonadotropic Hypogonadotropism","enrollment":84},{"nctId":"NCT07439536","phase":"PHASE4","title":"Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-07-01","conditions":"Liver Cirrhosis With Diabetes","enrollment":64},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT05653518","phase":"NA","title":"Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2023-09-09","conditions":"Type 1 Diabetes","enrollment":40},{"nctId":"NCT07186660","phase":"PHASE2","title":"Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2026-02-22","conditions":"Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus, Insulin","enrollment":40},{"nctId":"NCT07427134","phase":"NA","title":"Pediatric Insulin Plan Calculator for T1DM Management","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-03-01","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM), T1DM","enrollment":440},{"nctId":"NCT07430293","phase":"NA","title":"Hybrid Closed-Loop Insulin Delivery After Pancreatectomy","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2026-03-01","conditions":"Pancreatectomy, Total Pancreatectomy, Partial Pancreatectomy","enrollment":24},{"nctId":"NCT06449677","phase":"PHASE3","title":"Bionic Pancreas in CFRD","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2024-09-24","conditions":"Cystic Fibrosis-related Diabetes","enrollment":150},{"nctId":"NCT03905941","phase":"EARLY_PHASE1","title":"Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-08-23","conditions":"Polycystic Ovary Syndrome","enrollment":""},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT02616666","phase":"PHASE4","title":"A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2016-08-25","conditions":"Type 2 Diabetes Mellitus","enrollment":632},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT03514108","phase":"PHASE4","title":"DANHEART (H-HeFT and Met-HeFT)","status":"COMPLETED","sponsor":"Henrik Wiggers","startDate":"2018-03-01","conditions":"Heart Failure, Diabetes","enrollment":1100},{"nctId":"NCT00947726","phase":"NA","title":"Ceramide Containing Multivesicular Emulsion Application . . .","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2009-07","conditions":"Foot Transepidermal Water Loss in Patients in NIDDM, Foot Dryness in Patients With NIDDM","enrollment":10},{"nctId":"NCT05562492","phase":"NA","title":"Closed-loop for People Living With Cystic Fibrosis Related Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2023-04-12","conditions":"Cystic Fibrosis-related Diabetes","enrollment":128},{"nctId":"NCT05785832","phase":"NA","title":"A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2023-06-01","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":319},{"nctId":"NCT05279079","phase":"","title":"Markers in Acute Pancreatitis-1","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2023-01-25","conditions":"Acute Pancreatitis Drug-Induced","enrollment":175},{"nctId":"NCT07420972","phase":"NA","title":"Pilot Study of Intrapartum Insulin Pump","status":"NOT_YET_RECRUITING","sponsor":"Medstar Health Research Institute","startDate":"2026-04","conditions":"Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2), Pregnancy","enrollment":30},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT06111586","phase":"PHASE2","title":"FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-12-11","conditions":"Type 1 Diabetes Mellitus","enrollment":192},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT07287943","phase":"NA","title":"To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.","status":"RECRUITING","sponsor":"Viral N. Shah","startDate":"2026-02-09","conditions":"Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I","enrollment":34},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT06024928","phase":"NA","title":"Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2024-06-18","conditions":"Type 2 Diabetes","enrollment":23},{"nctId":"NCT05508061","phase":"NA","title":"Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"Inreda Diabetic B.V.","startDate":"2022-10-19","conditions":"Type 1 Diabetes","enrollment":12},{"nctId":"NCT07415226","phase":"","title":"Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-05-01","conditions":"Type 1 Diabetes Mellitus","enrollment":500},{"nctId":"NCT03695315","phase":"","title":"Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2018-10-31","conditions":"Obstructive Sleep Apnea, Hypoxia, Insulin Resistance","enrollment":48},{"nctId":"NCT03624062","phase":"PHASE1","title":"MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-08-31","conditions":"Type 1 Diabetes Mellitus","enrollment":21},{"nctId":"NCT06330194","phase":"NA","title":"Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-04-18","conditions":"Dialysis, Chronic Kidney Disease, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT06925217","phase":"NA","title":"Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes","status":"RECRUITING","sponsor":"Heba Al-Alwan","startDate":"2025-06-16","conditions":"Type 2 Diabetes, Chronic Kidney Disease Stage 3","enrollment":76},{"nctId":"NCT05944432","phase":"NA","title":"CGM Use in Adults With Type 2 Diabetes on Basal Insulin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abbott Diabetes Care","startDate":"2023-07-14","conditions":"Diabetes Mellitus, Type 2","enrollment":470},{"nctId":"NCT06227221","phase":"PHASE2","title":"Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-02","conditions":"Type 1 Diabetes","enrollment":10},{"nctId":"NCT07405944","phase":"PHASE4","title":"Vericiguat and Reverse Remodeling Indices in Heart Failure","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-11-01","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Heart Failure","enrollment":60},{"nctId":"NCT06598865","phase":"NA","title":"Comparative Effectiveness of Prescribed Adapted Physical Activity (APA), Either Practiced Independently After Training, or Supervised by an APA Teacher, on Glycemic Regulation in People With Unbalanced Type 2 Diabetes.","status":"RECRUITING","sponsor":"Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète","startDate":"2025-02-24","conditions":"Diabetes, Type 2, Non-Insulin Dependent, Poorly Controlled Diabetes Mellitus","enrollment":120},{"nctId":"NCT07401901","phase":"NA","title":"Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Medtronic Diabetes","startDate":"2026-07-15","conditions":"Type 1 Diabetes (T1D)","enrollment":230},{"nctId":"NCT07407881","phase":"NA","title":"Shot Blocker and Manual Pressure Application","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2025-07-25","conditions":"Injection Pain Prevention","enrollment":108},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT01794143","phase":"PHASE3","title":"A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes","status":"COMPLETED","sponsor":"GRADE Study Group","startDate":"2013-05","conditions":"Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications","enrollment":7850},{"nctId":"NCT05744856","phase":"NA","title":"A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam","status":"COMPLETED","sponsor":"Thai Binh University of Medicine and Pharmacy","startDate":"2023-01-16","conditions":"GDM","enrollment":435},{"nctId":"NCT06420661","phase":"NA","title":"School Partnered Collaborative Care (SPACE) Intervention for Children With Type 1 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"University of Pittsburgh","startDate":"2024-08-21","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT07226128","phase":"NA","title":"The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2026-02-15","conditions":"HIV, Depression in Adults, Insulin Resistance","enrollment":150},{"nctId":"NCT06185296","phase":"NA","title":"The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy","status":"RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2025-11-15","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":51},{"nctId":"NCT07173712","phase":"PHASE4","title":"Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Yanbing Li","startDate":"2026-03-15","conditions":"Type 2 Diabetes","enrollment":324},{"nctId":"NCT06986603","phase":"PHASE4","title":"Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Joslin Diabetes Center","startDate":"2024-11-26","conditions":"Hypoglycemia, Hypoglycemia, Reactive, Bariatric Surgery","enrollment":28},{"nctId":"NCT06883344","phase":"NA","title":"Automated Insulin for Management of Intrapartum Glycemia","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-12-05","conditions":"Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14339,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["insulin injection therapy"],"phase":"phase_3","status":"active","brandName":"Insulin therapy","genericName":"Insulin therapy","companyName":"Shanghai Jiao Tong University School of Medicine","companyId":"shanghai-jiao-tong-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin therapy replaces or supplements the body's own insulin to regulate blood glucose by promoting glucose uptake into cells and storage as glycogen. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient), Gestational diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}